Patent Protection Strategies
This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied […]
This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied […]
By: Pankaj Mondal, DrugPatentWatch Staff Writer The trillion dollar pharmaceutical sector has been dominated for long by a few giant
Factors that influence the development of generic drugs in the US Read Post »
We must achieve a balance between the current and future needs of patients and the timely introduction of existing and
A 2016 report by the Kaiser Family Foundation reported that approximately one-quarter of the people in the United States have
Re-Thinking Management Strategies for Specialty Drug Cost Containment Read Post »
This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which
Leveraging affordable innovation to tackle India’s healthcare challenge Read Post »
This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research 2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 © The Author(s). 2017 Abstract Background Policymakers and researchers
The steep rise in pharmaceutical prices year over year is old news at this point. Even a number of generic
Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare Read Post »
Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and
Should Price or Product Be the Determinant in Pharmaceutical Competition? Read Post »
We live in a digital world. The way we interact has undergone a tremendous change in the last decade and